Dr. Vijay Pande is a general partner at Andreessen Horowitz where he leads the firm’s investments focused on the cross section of biology and computer science including areas such as digital therapeutics, cloud biology and computational medicine. An entrepreneurial visionary behind the convergence of biology and computer science,

Dr. Pande is the founder of the Folding@Home Distributed Computing Project for disease research which pushes the boundaries of the development and application of computer science techniques (such as distributed systems, machine learning, and exotic computer architectures) into biology and medicine, in both fundamental research as well as the development of new therapeutics.

Previously, Dr. Pande was The Camille and Henry Dreyfus Professor of Chemistry and Professor of Structural Biology and of Computer Science at Stanford University. In this capacity, he led an award winning group pioneering computational methods and their application to medicine and biology, resulting in over 200 publications, two patents and two novel drug treatments. Concurrently, he was the director of the Biophysics program at Stanford where he led a team of over 50 Stanford faculty members and propelled the program to the top rated in the country.

Also during his time at Stanford, Dr. Pande co-founded Globavir Biosciences, where he translated his research advances at Stanford and Folding@Home into a successful startup, discovering cures for Dengue Fever and Ebola. Dr. Pande remains a close advisor to Globavir Biosciences. Dr. Pande received a BA in Physics from Princeton University and a PhD in Physics from MIT. He was awarded the DeLano Prize in Computation, Guinness World Record for Folding@Home, ACS Thomas Kuhn Paradigm Shift Award, and MIT TR100.

Dr. Pande serves on the board of an Andreessen Horowitz portfolio company, Omada Health, and leads the firm’s investment in Benching, TwoXAR and uBiome.

Prior to co-founding twoXAR, Andrew held Chief Technology Officer roles at several early stage companies where he managed teams as large as a hundred technologists distributed around the world. Andrew developed the company's proprietary algorithm and as Chief Executive Officer is focused on overall company strategy, product development and fundraising. Andrew studied biomedical informatics in Stanford University's SCPD graduate program and holds Master of Science and Bachelor of Science degrees in computer science from Rochester Institute of Technology.

Hugo leads the science and bioinformatics teams at Bina, directing the research and development progress towards more accurate, robust and faster pipelines for analyzing and interpreting genomics data. He brings over ten years experience in IT and genomics, including time at 23andMe and Personalis. Hugo received his bachelor's degree in biology from the Hong Kong University of Science and Technology and his master's degree in computer science from the Imperial College London. He also holds a Ph.D. in Computational Biology and Bioinformatics from Yale and was a postdoctoral scholar in Bioinformatics at Stanford. In his free time, Hugo enjoys swimming and playing snookers

Dr. Cavet is a co-founder of Atreca. He previously led informatics and computational biology at multiple biotechnology and information technology companies, including as a vice president at Crescendo Bioscience, where he was instrumental in developing Vectra® DA, their marketed diagnostic product. Prior to Atreca, Dr. Cavet was Chief Information Officer and Head of Computational Sciences at Nodality. He has also led informatics and computational biology teams at Genentech, Merck, and Rosetta Inpharmatics. Dr. Cavet received BS and PhD degrees in Biochemistry from Cambridge University, and he performed postdoctoral research at Stanford University.

Dr. Pravene A. Nath is the Chief Information Oficer of Stanford Health Care. He leads technology strategy and operations for the health system, which includes acute and ambulatory care facilities and health plans, collectively serving more than one million patients each year. Under Dr. Nath’s leadership, Stanford Health Care has pioneered the development of virtual care and the use of cloud technologies in healthcare. The health system has been recognized with the Hospital & Health Network’s Most Wired Hospital Award, HIMSS Analytics Stage 7 EMR Adoption and Leapfrog Top Hospital honors. Dr. Nath has served in both healthcare IT and clinical leadership positions. He held the role of Chief Medical Information Oficer at both Stanford Health Care and NYU Langone Medical Center and has practiced as a member of the teaching faculty at Stanford as well as NYU and Bellevue Hospitals, where he completed his residency training. Dr. Nath received his B.S.E. in biomedical engineering from Duke University and his M.D. and M.S.E. in biomedical engineering from The University of Michigan.

Dr. Hill is an expert in genetics, molecular biology, and bioinformatics. While in graduate school at Stanford, Dr. Hill constructed the first genetic map of a chordate model organism which led to important insights about the nature of genome evolution. He simultaneously developed an algorithm that reduced the compute time required for whole genome sequence alignments from weeks to hours. His prior industry experience involved developing techniques for interrogating the function of genes. Since joining Natera in early 2009, he has been instrumental in leading the research and development of single-gene PGD, translocation testing, carrier screening, non-invasive paternity testing, and non-invasive prenatal testing. Dr. Hill received is B.S. in Biology from Cornell University and a Ph.D. in Genetics from Stanford University.